Pharmacoeconomics: friend or foe?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17038472.
- Also identified by PMC identifier 1798382.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The financial constraints faced by most health systems today make it necessary for manufacturers of new, expensive drugs to demonstrate value for money. This paper describes the different types of economic evaluation; the increasing use of these analysis in decision making; their application to new drugs in the field of in rheumatoid arthritis; and the pros and cons of pharmacoeconomics studies from the perspective of the patients, the physicians, and the general population.
Medical subject headings
- Economics, Pharmaceutical